Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Aug 6, 2011; 2(4): 27-35
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Table 6 Assessment of stress ulcer prophylaxis practice per hospital type n (%)
SUP variable | Teaching | Non-teaching | P-value |
Indication | |||
Candidates | 153 (37.8) | 178 (29.7) | |
Non-candidates | 252 (62.2) | 421 (70.3) | 0.008 |
Dose | |||
Appropriate | 350 (86.4) | 541 (90.6) | |
Inappropriate | 55 (13.6) | 56 (9.4) | 0.038 |
Route | |||
Appropriate | 206 (50.9) | 245 (40.9) | |
Inappropriate | 199 (49.1) | 354 (59.1) | 0.002 |
Dose and route | |||
Appropriate | 178 (44.0) | 211 (35.2) | |
Inappropriate | 227 (56.0) | 388 (64.8) | 0.005 |
Acid-suppressant drugs | |||
PPIs | 266 (65.7) | 352 (58.8) | |
H2-RAs | 139 (34.3) | 247 (41.2) | 0.027 |
Duration (d) | |||
Median (IQR)1 | 5 (10) | 3 (3.75) | < 0.0011 |
Discharge on SUP | |||
Yes | 53 (26.2) | 66 (21.8) | |
No | 149 (73.8) | 237 (78.2) | 0.248 |
- Citation: Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther 2011; 2(4): 27-35
- URL: https://www.wjgnet.com/2150-5349/full/v2/i4/27.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v2.i4.27